Food and Drug Administration, HHS.
Final rule; technical amendment.
The Food and Drug Administration (FDA) is amending its regulations to correct an inadvertent error that has been incorporated into the public information regulations. This action is being taken to ensure the accuracy and consistency of the regulations.
This rule is effective March 26, 2002.Start Further Info
FOR FURTHER INFORMATION CONTACT:
Doris Tucker, Office of Policy, Planning, and Legislation (HF-27), Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20857, 301-827-7010.End Further Info End Preamble Start Supplemental Information
FDA has discovered that an error has been incorporated into the agency's regulations for 21 CFR part 20. This document corrects that error. Publication of this document constitutes final action under the Administrative Procedure Act (5 U.S.C. 553). FDA has determined that notice and public comment are unnecessary because this amendment is nonsubstantive.Start List of Subjects
List of Subjects in 21 CFR Part 20
- Confidential business information
- Freedom of information
- Government employees
Therefore, under the Federal Food, Drug, and Cosmetic Act and under authority delegated to the Commissioner of Food and Drugs, 21 CFR part 20 is amended as follows:End Amendment Part Start Part
PART 20—PUBLIC INFORMATIONEnd Part Start Amendment Part
1. The authority citation for 21 CFR part 20 continues to read as follows:End Amendment Part
2. Section 20.100 Applicability; cross-reference to other regulations is amended by removing paragraph (c)(30) and redesignating paragraphs (c)(31) through (c)(41) as paragraphs (c)(30) through (c)(40), respectively.Start Signature
Dated: March 19, 2002.
Margaret M. Dotzel,
Associate Commissioner for Policy.
[FR Doc. 02-7180 Filed 3-25-02; 8:45 am]
BILLING CODE 4160-01-S